founder & CEO of QureBio
QureBio is a Shanghai-based biopharmaceutical company developing bispecific and multispecific antibody therapies targeting cancer, autoimmune, and inflammatory diseases. Founded by Dr. Xiangdong Qu, it partners with global biotech firms and has raised significant funding, including a ¥100M Series C1 round in 2025.